-
-
-
-
-
-
-
Piper Sandler Downgrades Capricor Therapeutics (CAPR) to Neutral
-
-
-
-
-
-
-
Jones Trading on Capricor Therapeutics (CAPR): 'this is the first time we have seen the magnitude of difference in primary outcome'
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
-
-
-
-
-
-
-
FDA staff says evidence lacking for compounding peptides
-
-
-
-
-
-
-
Radcom unveils new analytics module for telecom operators
-
-
-
-
-
-
-
Jefferies Downgrades Abivax (ABVX) to Hold
-
-
-
-
-
-
-
Glimpse Group shifts to pureplay Physical AI focus
-
15,832 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

